Currently, melanoma remains a surgical disease since early detection and excision of thin
melanomas offers the best chance of a cure. Despite intensive clinical investigation, no …

Purpose: L612, a human IgM monoclonal antibody produced by an EBV-transformed human
B-cell line, binds to ganglioside GM3 and kills GM3-positive human melanoma cells in the …

Purpose: There is no consensus regarding the optimal tumor markers for melanoma. We
compared 3 tumor markers, TA90-immune complex (TA90IC), melanoma-inhibiting activity …

Melanoma patients in stage III have a considerable recurrence rate. The 10‐year survival in
this stage depends on the number and size of affected nodes. Currently, there is no optimal …

Regional treatments including chemotherapy have been applied to patients with malignant
melanoma metastasis to the liver in clinical trials, but with limited efficacy. To improve …

5‐S‐l‐Cysteinyl‐l‐dopa is a well‐known pigment intermediate and analysis of its serum
concentration is well suited for evaluation of treatment and follow‐up of stage III and IV …

A melanoma malignum a neuroektodermalis eredetu melanocitákból kiinduló legrosszabb
indulatú bordaganat. Incidenciája évente 3-7%-kal növekszik (49,110,132,140). Az …

Melanoma malignumban a keringô tumormarkereknek potenciális szerepe a prognózis
felállításában, a betegkövetésben és a terápia monitorozásban lehet. A közleményben …